![]() NeRRe Therapeutics NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. | ![]() OCTIMET Oncology OCTIMET develops highly selective MET kinase inhibitors with clean safety profiles from Janssen Pharmaceutica. | ![]() CELLEX CELLEX (also known as BioCom and Biomedical Components) is a company specializing in the development of bioreactors for advanced cell culture and tissue engineering. | ||
Founding Date | Founding Date 2012 | Founding Date 2003 | Founding Date 2016 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Stevenage, GB HQ Hertfordshire, GB | Locations Newark, US HQ | Locations Beerse, BE HQ Gent, BE | Locations Roma, IT HQ |
Employees | Employees 9 | Employees 1292% increase | Employees 1 | Employees 1 |
Funding | ||||
Latest funding round | Latest funding round $ 30.8m (over 9 years ago) | Latest funding round N/A | Latest funding round $ 13.4m (over 9 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 49.2m | Total funding raised N/A | Total funding raised $ 13.4m | Total funding raised N/A |

The leading Gene Synthesis and Bioengineering Solutions company.
View company
OCTIMET develops highly selective MET kinase inhibitors with clean safety profiles from Janssen Pharmaceutica.
View company
CELLEX (also known as BioCom and Biomedical Components) is a company specializing in the development of bioreactors for advanced cell culture and tissue engineering.
View company